| mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
0.007 |
0.8 |
| mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
-0.008 |
0.9 |
| mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.9 |
| mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.9 |
| mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |
| mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.9 |
| mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
KU 0060648 |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.9 |